Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2020.

On November 4, 2020, ERYTECH Pharma announced its share capital details.

Rhea-AI Summary

On November 4, 2020, ERYTECH Pharma announced its share capital details. As of October 31, 2020, the company had a total of 19,081,988 shares and 20,616,679 gross voting rights, with net voting rights at 20,614,179. The report includes data from prior months, showing a gradual increase in both shares and voting rights. ERYTECH is listed on Euronext Paris and the Nasdaq Global Select Market. This update complies with regulatory requirements specified by the French Autorité des Marchés Financiers.

Positive

• Increase in total shares from 17,940,035 in December 2019 to 19,081,988 by October 2020.
• Gross voting rights rose from 19,534,014 to 20,616,679 during the same period.
• Net voting rights improved from 19,531,514 to 20,614,179.

Negative

• None.

Argus Session date unavailable

+10.88% session move Open Argus

Details

News Market Reaction – ERYP

The recorded move for ERYP in the trading session of this news was +10.88%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Article 223-16 of general regulation of French Autorité des Marchés Financiers

LYON, France, Nov. 04, 2020 (GLOBE NEWSWIRE) --

Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &
Nasdaq Global Select Market in the United-States (Symbol : ERYP)
Website : www.erytech.com

Date	Total of shares composing the share capital	Total of brut (1) voting rights	Total of net (2) voting rights
December 31,2019	17 940 035	19 534 014	19 531 514
January 31, 2020	17 940 035	19 534 260	19 531 760
February 29, 2020	17 940 035	19 534 260	19 531 760
March 31, 2020	17 940 035	19 536 736	19 534 236
April 30, 2020	17 940 035	19 536 806	19 534 306
May 30, 2020	17 940 035	19 489 410	19 486 910
June 30, 2020	17 956 115	19 495 805	19 493 305
July 31, 2020	18 081 843	19 616 534	19 614 034
August 31, 2020	18 301 621	19 836 312	19 833 812
September 30,2020	18 995 590	20 530 281	20 527 781
October 31, 2020	19 081 988	20 616 679	20 614 179

⁽¹⁾   Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
⁽²⁾   Without treasury shares.

PDF available at: http://ml.globenewswire.com/Resource/Download/10964fbd-e414-48e5-a0b0-252a1d76496c

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the latest share capital figures for ERYP as of October 31, 2020?

As of October 31, 2020, ERYTECH Pharma reported a total of 19,081,988 shares and 20,616,679 gross voting rights.

How have ERYP's voting rights changed over time?

From December 2019 to October 2020, gross voting rights increased from 19,534,014 to 20,616,679, with net voting rights rising from 19,531,514 to 20,614,179.

On which stock exchanges is ERYP listed?

ERYTECH Pharma is listed on Euronext Paris and the Nasdaq Global Select Market.

What regulations is ERYP complying with regarding share capital disclosures?

ERYTECH is complying with Article 223-16 of the general regulations of the French Autorité des Marchés Financiers.